https://www.indianpharmapost.com/mankind-pharma-completes-acquisition-of-bsv-163572024-10-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-lal-pathlabs-q2-fy25-consolidated-net-profit-up-at-rs-1292-cr-163582024-10-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/thyrocare-technologies-posts-q2-fy25-consolidated-net-profit-at-of-rs-2667-cr-163592024-10-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/jagsonpal-pharmaceuticals-q2-fy25-net-profit-up-at-rs-1145-cr-163602024-10-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/syngene-international-posts-q2-fy25-consolidated-pat-at-rs-1061-cr-163612024-10-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/piramal-pharma-reports-q2-fy25-consolidated-pat-at-rs-2259-cr-163622024-10-25T00:00:00+05:30always0.9